Home
December 2008 January 2009 February 2009
Su Mo Tu We Th Fr Sa
Week 1 1 2 3
Week 2 4 5 6 7 8 9 10
Week 3 11 12 13 14 15 16 17
Week 4 18 19 20 21 22 23 24
Week 5 25 26 27 28 29 30 31

The Prostate Cancer Symposium (TPCS) 2007 Abstracts - Androgen Deprivation Therapy
TPCS 2007 ABST[190] - Time to Return to Baseline Testosterone Level and the Risk of Death from Prostate Cancer in Men Who Received Radiation and 6 Months of Androgen Suppression Therapy.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[191] - Use of Androgen Deprivation Therapy (ADT) Does Not Affect Cognitive Function in Prostate Cancer.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[192] - A One-Year, North American Multicenter, Randomized Dose-Finding Study of Degarelix, a Gonadotropin-Releasing Hormone (Gnrh) Receptor Blocker, in Prostate Cancer Patients.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[193] - Role of Androgen Deprivation Therapy (ADT) for Node-Positive Prostate Cancer.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[194] - Phase II Trial of Combination Low-Dose Flutamide Plus Finasteride Versus Low-Dose Flutamide Monotherapy for Biochemical Recurrence Following Definitive Therapy for Prostate Cancer: Long-Term Follow-Up.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[195] - Variance in Physician Attitudes toward Androgen Deprivation Therapy Initiation for Rising PSA for Asymptomatic Recurrent Prostate Cancer.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[196] - Hormone Therapy for Prostate Cancer--Is Cure Possible after All?
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[197] - Induced Castration in Rattus Norvegiccus Albinus Through Percutaneous Testis Sclerosing. an Alternative for Orchiectomy in Metastatic Prostate Cancer?
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[198] - Zoledronic Acid Reduces Bone Loss in Men with Prostate Cancer Receiving Goserelin: 12-Month Results.
Friday, 23 February 2007
Login to read more...

TPCS 2007 ABST[285] - The Role of Neoadjuvant Androgen Deprivation in Patients with Intermediate- and High-Risk Prostate Cancer Receiving High- Dose-Rate Brachytherapy and External Beam Radiotherapy.
Friday, 23 February 2007
Login to read more...

 
<< Start < Prev 1 Next > End >>
Results 1 - 10 of 10
back

UroToday, 1802 Fifth Street, Berkeley CA 94710
510.540.0930 (fax), info@urotoday.com
ISSN 1939-4810
About The Editors | About Us | Contact Us | Sponsorship Opportunities | Terms of Use


Privacy Policy | © 2008 UroToday ® All Rights Reserved